Cargando…
A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375643/ https://www.ncbi.nlm.nih.gov/pubmed/35973595 http://dx.doi.org/10.1016/j.kint.2022.07.022 |
_version_ | 1784768010326638592 |
---|---|
author | Benotmane, Ilies Velay, Aurélie Vargas, Gabriela-Gautier Olagne, Jérôme Cognard, Noëlle Heibel, Françoise Braun-Parvez, Laura Martzloff, Jonas Perrin, Peggy Pszczolinski, Romain Moulin, Bruno Fafi-Kremer, Samira Caillard, Sophie |
author_facet | Benotmane, Ilies Velay, Aurélie Vargas, Gabriela-Gautier Olagne, Jérôme Cognard, Noëlle Heibel, Françoise Braun-Parvez, Laura Martzloff, Jonas Perrin, Peggy Pszczolinski, Romain Moulin, Bruno Fafi-Kremer, Samira Caillard, Sophie |
author_sort | Benotmane, Ilies |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9375643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | International Society of Nephrology. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93756432022-08-15 A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration Benotmane, Ilies Velay, Aurélie Vargas, Gabriela-Gautier Olagne, Jérôme Cognard, Noëlle Heibel, Françoise Braun-Parvez, Laura Martzloff, Jonas Perrin, Peggy Pszczolinski, Romain Moulin, Bruno Fafi-Kremer, Samira Caillard, Sophie Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2022-11 2022-08-13 /pmc/articles/PMC9375643/ /pubmed/35973595 http://dx.doi.org/10.1016/j.kint.2022.07.022 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Benotmane, Ilies Velay, Aurélie Vargas, Gabriela-Gautier Olagne, Jérôme Cognard, Noëlle Heibel, Françoise Braun-Parvez, Laura Martzloff, Jonas Perrin, Peggy Pszczolinski, Romain Moulin, Bruno Fafi-Kremer, Samira Caillard, Sophie A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration |
title | A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration |
title_full | A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration |
title_fullStr | A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration |
title_full_unstemmed | A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration |
title_short | A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration |
title_sort | rapid decline in the anti–receptor-binding domain of the sars-cov-2 spike protein igg titer in kidney transplant recipients after tixagevimab–cilgavimab administration |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375643/ https://www.ncbi.nlm.nih.gov/pubmed/35973595 http://dx.doi.org/10.1016/j.kint.2022.07.022 |
work_keys_str_mv | AT benotmaneilies arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT velayaurelie arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT vargasgabrielagautier arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT olagnejerome arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT cognardnoelle arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT heibelfrancoise arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT braunparvezlaura arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT martzloffjonas arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT perrinpeggy arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT pszczolinskiromain arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT moulinbruno arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT fafikremersamira arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT caillardsophie arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT benotmaneilies rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT velayaurelie rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT vargasgabrielagautier rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT olagnejerome rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT cognardnoelle rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT heibelfrancoise rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT braunparvezlaura rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT martzloffjonas rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT perrinpeggy rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT pszczolinskiromain rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT moulinbruno rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT fafikremersamira rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration AT caillardsophie rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration |